Lessons From Taxanes Versus Eribulin for First-Line Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the EMERALD Study ASCO Guidelines provide recommendations with ...

Finding the Right Partner: Triplet Therapy for First-Line Advanced Biliary Tract Cancers BV combined with Len + R demonstrated significant improvements in overall survival (OS; 37% reduced risk of ...

What Are the Real Pros of Real-Time PROs (Patient-Reported Outcomes)? The following represents disclosure information provided by the author of this manuscript. All relationships are considered ...

The growing sophistication of tumor molecular profiling has helped to slowly transition oncologic care toward a more personalized approach in different tumor types, including in bladder cancer. The ...

Feasibility and Acceptability of Collecting Passive Smartphone Data for Potential Use in Digital Phenotyping Among Family Caregivers and Patients With Advanced Cancer Calibration-free odds type ...

Feasibility of Multi-Institutional Data Collection for Medication Prior Authorization in Pediatric Oncology Interestingly, though, the Danish multicenter randomized study 6 did not reproduce the ...

Tailored Approaches in the Treatment of Patients With Colorectal Cancer Harboring Tropomyosin Receptor Kinase Fusion and Microsatellite Instability-High: A Case Report and Literature Review The ...

Clinical outcomes and changes in body composition following endoscopic submucosal dissection versus total gastrectomy in patients with proximal early gastric cancer. Comparison between neoadjuvant ...

Niraparib in patients with BRCA-mutated unresectable or recurrent biliary tract, pancreatic and other gastrointestinal cancers: An investigator-initiated phase 2 trial (NIR-B trial). This is an ASCO ...

Impact of inpatient palliative care consultation on end-of-life care among patients with esophageal cancer. Preliminary results from the multicenter, randomized phase III trial (SCIENCE): Comparing ...